3Ryu S, Chang Y,, Kim DI, et al. gammaGlutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men [J]. ClinChem, 2007,53 (1) : 71-77.
4Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease [J]. Atherosclerosis, 2007,191 (2) :235-240.
4Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients [ J ]. Diabetes Care, 2007,30 (5) :1212 -1218.
5Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease : evaluation, classification, and stratification [ J ]. Ann Intern Med, 2003, 139 ( 2 ) : 137 - 147.
6Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients[ J]. Diabetologia,2008,51 (3) :444 - 450.
7Leite NC,Salles GF, Araujo AL, et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus[ J]. Liver Int,2009,29( 1 ) :113 - 119.
8Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla[ J ]. Hypertension,2001,37 (2) :547 - 553.
9Ryu S, Chang Y, Kim DI, et al. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetie Korean men[ J]. Clin Chem,2007,53( 1 ) :71 -77.
10Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease [ J ]. Atherosclerosis, 2007, 191 (2) :235 -240.
